Dr. Rayaz Ahmed

About Dr. Rayaz Ahmed

• Dr. Rayaz Ahmed, currently working as Senior Director of Oncology, Bone Marrow Transplant & Hemato-Oncology at Max Healthcare.
• He has successfully performed over 1000 Bone Marrow Transplant In 17+ years of clinical experience.
• Previously held the position of Senior Consultant in the Department of Hematology at Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, where he advanced complex hematological care.
• Dr. Ahmed also served as Associate Professor in the Department of Hematology at Christian Medical College (CMC), Vellore
• Retry

Special Interest

• Autologous Stem Cell Transplantation, from patient’s own stem cells
• Allogeneic Stem Cell Transplantation, Matched Sibling Donor procedures
• Haploidentical Stem Cell Transplants
• Matched Unrelated Donor Stem Cell Transplants
• Aplastic Anemia patients
• Thalassemia treatment protocols
• Sickle Cell Anemia management
• Leukemia including Acute (AML), (ALL), (CML), and (CLL).
• Hodgkin and Non-Hodgkin Lymphomas
• Multiple Myeloma treatment

Education

• MBBS from Pt. Ravi Shanker University, Raipur, Chhattisgarh, India in 1999
• MD degree from Shivaji University Kolhapur, Maharashtra in 2003
• DM (Doctorate of Medicine) in Hematology from the prestigious Christian Medical College & Hospital, Vellore, Tamil Nadu in 2010

Treatment

Awards

Successfully conducted a comprehensive range of bone marrow transplant procedures, including Autologous, Matched Sibling Donor (MSD), Matched Unrelated Donor (MUD), and Haploidentical (Haplo) Allogeneic transplantations.

Awarded the prestigious University Gold Medal in MD Pathology in 2003 by Shivaji University, Kolhapur, Maharashtra, recognizing his exceptional academic excellence and outstanding performance.

Research Papers & Publications

• Research for long-term outcomes of splenectomy for chronic ITP in adults and children.
• Factors affecting imatinib adherence in Indian chronic myeloid leukemia patients.
• Dr. Ahmed investigated BRAF mutations in hairy cell leukemia patients.
• He analyzed fludarabine-based conditioning regimens for severe aplastic anemia across three Indian centers.
• Dr. Ahmed identified novel transferrin mutations causing microcytic anemia and hemosiderosis.
• He evaluated cost-effective treatment protocols for T-cell acute lymphoblastic leukemia in India.
• Dr. Ahmed demonstrated improved outcomes in high-risk thalassemia patients using treosulfan-based transplant protocols.
• He characterized BCR/ABL1 fusion patterns in chronic myelogenous leukemia diagnosis.
• Dr. Ahmed studied the molecular basis of Wiskott-Aldrich syndrome in Indian patients.
• He investigated carbonyl reductase 1 expression effects on daunorubicin metabolism in acute myeloid leukemia.